XML 23 R4.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue:        
Collaboration revenue $ (3,677,000) $ 2,443,000 $ (2,601,000) $ 16,473,000
Total revenue (3,677,000) 2,443,000 (2,601,000) 16,473,000
Operating expenses:        
Research and development expense 16,457,000 9,139,000 37,562,000 22,222,000
General and administrative expense 2,947,000 2,424,000 8,937,000 7,227,000
Total operating expenses 19,404,000 11,563,000 46,499,000 29,449,000
Operating loss (23,081,000) (9,120,000) (49,100,000) (12,976,000)
Other (expense) income, net:        
Dividend income 2,000 2,000 5,000 45,000
Interest income 8,000 205,000 139,000 832,000
Interest expense (455,000) (27,000) (1,314,000) (155,000)
Other (expense) income, net (5,000) 118,000 (7,000) 271,000
Total other (expense) income, net (450,000) 298,000 (1,177,000) 993,000
Net loss before provision for income taxes (23,531,000) (8,822,000) (50,277,000) (11,983,000)
Provision for income taxes 0 0 0 0
Net loss $ (23,531,000) $ (8,822,000) $ (50,277,000) $ (11,983,000)
Basic (loss) earnings per common share (USD per share) $ (0.27) $ (0.10) $ (0.57) $ (0.14)
Diluted (loss) earnings per common share (USD per share) $ (0.27) $ (0.10) $ (0.57) $ (0.14)
Weighted-average basic common shares outstanding (in shares) 88,105,066 87,227,136 88,001,222 87,160,520
Weighted-average diluted common shares outstanding (in shares) 88,105,066 87,227,136 88,001,222 87,160,520